Advisory Board and Editors Nephrology

PeerJ Factsheet
A one-page facts and stats PDF, to help when considering journal options with your co-authors.
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

David Kennedy

Our lab studies how interrelated organ systems such as heart, kidney and liver regulate cellular damage (particularly inflammation and fibrosis) and repair during the course of chronic ailments such as heart failure, hypertension, diabetes, obesity and chronic kidney disease. We are particularly interested in developing new preventative and therapeutic strategies to help people suffering from these diseases through establishing novel biomarkers and molecular diagnostics to assist risk stratification as well as identifying new drugs and drug targets and enhancing endogenous counter-regulatory mechanisms. Given our community’s ties to and dependence on the Great Lakes as a source of clean water for drinking, recreation, fishing and agriculture, our laboratory also places a special emphasis on discovering new diagnostic, preventative and therapeutic strategies targeting cellular damage caused by environmental stressors that impair our land-water-food nexus.

John Knight

John trained in paediatrics and nephrology in Sydney and London, then worked as an academic paediatric nephrologist at the Royal Alexandra Hospital for Children in Sydney, where he founded the Centre for Kidney Research. For four years he was Medical Director of the Australian Kidney Foundation. Then he worked in therapeutic risk management and pharmacovigilance for a decade for Johnson and Johnson in Europe and Asia. He returned to academia in 2014 as a Professorial Fellow at the George Institute for Global Health in Sydney, where he is also Director of China-Australia Partnerships. His current research concerns dialysis access and outcomes, particularly in resource constrained environments.

Florian Lang

Professor of Physiology and Head of the Department for Physiology I in Tübingen, Member of the German Academy of Natural Sciences Leopoldina. Former President of the Geman Physiological Society and the Germany Society of Nephrology.

Stefano Menini

Associate professor of Human Nutrition, School of Medicine and Psychology, Department of Clinical and Molecular Medicine, "La Sapienza" University, Rome, Italy. PhD in Biology and Pathology of Ageing and member of the European Association for the Study of Diabetes (EASD). Research areas: Diabetes, Endocrinology and Metabolism.

Gianpaolo Reboldi

Professor of Nephrology and Consultant Physician at the University of Perugia

Academic Degrees:
Doctoral Degree in Medicine and Surgery (MD) from the Faculty of Medicine and Surgery, University of Perugia, Italy
Master of Science (MSc) from The Faculty of Medicine, University of Newcastle upon Tyne, Newcastle Upon Tyne, United Kingdom
Dottore di Ricerca (PhD) in Applied Pathophysiology from The University of Florence, Florence, Italy

Scientific Interests:
Cardiovascular and Renal Diseases, Diabetes, Hypertension, Geriatric Endocrinology, Clinical Pharmacology and Pharmacokinetics, Biostatistics, Clinical Epidemiology, and Medical Informatics.

Giuseppe Remuzzi

Prof. of Nephrology, Director of the Department of Immunology and Clinical Transplantation and Director of the Department of Medicine of the Ospedali Riuniti di Bergamo, Italy. Research Coordinator of the Negri Bergamo Laboratories of the Mario Negri Institute for Pharmacological Research. Recipient of ISN Jean Hamburger Award (2005), ASN John. P. Peters Award (2007), ISN AMGEN Award (2011). 2011 appointed as ISN President-elect (2013-2015)

Paul M. Tulkens

Emeritus Professor of Pharmacology (Catholic University of Louvain, Brussels, Belgium) and Emeritus Professor of Human Biochemistry and Biochemical Pathology (University of Mons, Mons, Belgium).

Emeritus since 2010, he maintains active research activities and is currently Section Editor of the International Journal of Antimicrobial Agents, Editor of Antimicrobial Agents and Chemotherapy, and Biomed Research International, and a frequent reviewer for many biomedical journals.